MRNA logo

Moderna WBAG:MRNA Stock Report

Last Price

€102.46

Market Cap

€38.0b

7D

9.1%

1Y

-25.1%

Updated

27 Mar, 2024

Data

Company Financials +

MRNA Stock Overview

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally.

MRNA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Moderna, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Moderna
Historical stock prices
Current Share PriceUS$102.46
52 Week HighUS$148.18
52 Week LowUS$64.46
Beta1.6
1 Month Change19.71%
3 Month Change13.05%
1 Year Change-25.06%
3 Year Changen/a
5 Year Changen/a
Change since IPO-47.76%

Recent News & Updates

Recent updates

Shareholder Returns

MRNAAT BiotechsAT Market
7D9.1%4.3%1.5%
1Y-25.1%-2.7%6.5%

Return vs Industry: MRNA underperformed the Austrian Biotechs industry which returned -1.1% over the past year.

Return vs Market: MRNA underperformed the Austrian Market which returned 6.9% over the past year.

Price Volatility

Is MRNA's price volatile compared to industry and market?
MRNA volatility
MRNA Average Weekly Movement8.3%
Biotechs Industry Average Movement7.4%
Market Average Movement3.3%
10% most volatile stocks in AT Market4.8%
10% least volatile stocks in AT Market1.6%

Stable Share Price: MRNA has not had significant price volatility in the past 3 months.

Volatility Over Time: MRNA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Austrian stocks.

About the Company

FoundedEmployeesCEOWebsite
20105,600Stephane Bancelhttps://www.modernatx.com

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics.

Moderna, Inc. Fundamentals Summary

How do Moderna's earnings and revenue compare to its market cap?
MRNA fundamental statistics
Market cap€37.99b
Earnings (TTM)-€4.35b
Revenue (TTM)€6.33b

6.2x

P/S Ratio

-9.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MRNA income statement (TTM)
RevenueUS$6.85b
Cost of RevenueUS$9.54b
Gross Profit-US$2.69b
Other ExpensesUS$2.02b
Earnings-US$4.71b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-12.31
Gross Margin-39.28%
Net Profit Margin-68.84%
Debt/Equity Ratio0%

How did MRNA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.